Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAMSCs for Wound Healing in Uremic Calciphylaxis
NCT04592640Phase 1Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2018
- Primary completion
- Sep 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of human amniotic mesenchymal stem cells in calciphylaxis (CUA), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Wound Healing at 1 year. Started Sep 2018; status: recruiting.
02
Drugs
human amniotic mesenchymal stem cells
03
Conditions
calciphylaxis (CUA)
Beyond the preview
Go deeper on NCT04592640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592640.